Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2023 Financial Results

2024-01-16

财报

WARSAW, Ind., Jan. 16, 2024 /PRNewswire/ --Zimmer Biomet (Formerly Known As Biomet Inc.) Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 8, 2024 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET. The live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at . It will be available for replay following the conference call. Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (888) 204-4368 and using conference ID 5103691. International callers should dial +1 (323) 994-2093 and use conference ID 5103691. Additionally, Zimmer Biomet will host an in-person product showcase event for investors and analysts at the American Academy of Orthopaedic Surgeons Conference in San Francisco. The event will take place on Tuesday, February 13, 2024 at 5:30 p.m. PT. Please register prior to attending the event via Zimmer Biomet's Investor Relations website at . About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit or follow Zimmer Biomet on Twitter at . Media Heather Zoumas-Lubeski (445) 248-0577 heather.zoumaslubeski@zimmerbiomet.com Investors Zach Weiner (908) 591-6955 zach.weiner@zimmerbiomet.com Company Codes: Swiss:ZBH, NYSE:ZBH

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构